The US Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with “human-relevant methods,” including the use of AI-based models.
By REUTERS
04/10/2025 11:23 PM
By REUTERS
04/10/2025 10:15 PM
By REUTERS
04/10/2025 10:15 PM
By MAARIV
04/10/2025 07:50 PM
04/10/2025 07:33 PM
04/10/2025 06:57 PM
By REUTERS
04/10/2025 06:40 PM
By REUTERS
04/10/2025 06:30 PM
04/10/2025 05:57 PM
By HODIA RAN
04/10/2025 05:35 PM
By REUTERS
04/10/2025 02:27 PM
By REUTERS
04/10/2025 02:04 PM
By REUTERS
04/10/2025 11:13 AM
By REUTERS
04/10/2025 10:00 AM
04/10/2025 08:54 AM